Belinda Maher
Clayton, QLD, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Discovery and Characterization of VPRBP/DCAF1 Kinase Inhibitor Analogs as Microtubular Destabilizing Agents with Potent Antimyeloma Activity.
Journal: Molecular cancer therapeutics
Published: April 01, 2025
VHL-independent degradation of hepatitis B virus e antigen (HBeAg) by VHL-binding chimeric small molecules.
Journal: RSC medicinal chemistry
Published: February 06, 2025
Targeted protein degraders of SARS-CoV-2 Mpro are more active than enzymatic inhibition alone with activity against nirmatrelvir resistant virus.
Journal: Communications medicine
Published: November 21, 2024
Mapping the IMiD-dependent cereblon interactome using BioID-proximity labelling.
Journal: The FEBS journal
Published: December 03, 2023
Rationally designed chimeric PI3K-BET bromodomain inhibitors elicit curative responses in MYC-driven lymphoma.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 29, 2023
High Throughput Screening Targeting the Dengue NS3-NS5 Interface Identifies Antivirals against Dengue, Zika and West Nile Viruses.
Journal: Cells
Published: December 27, 2021
Novel Flavivirus Antiviral That Targets the Host Nuclear Transport Importin α/β1 Heterodimer.
Journal: Cells
Published: February 12, 2019
A nuclear transport inhibitor that modulates the unfolded protein response and provides in vivo protection against lethal dengue virus infection.
Journal: The Journal of infectious diseases
Published: June 07, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026